An Anti-Tissue Factor Pathway Inhibitor (TFPI) Monoclonal Antibody Recognized the Third Kunitz Domain (K3) of Free-Form TFPI but Not Lipoprotein-Associated Forms in Plasma1
Takeo Abumiya(Hokkaido University), Hisao Kato(National Cerebral and Cardiovascular Center), Keiichi Enjyoji(Beth Israel Deaconess Hospital), Yuichi Kamikubo(Thrombosis Research Institute), Toshinori Kokawa(National Cerebral and Cardiovascular Center)
Cited by 52
Related Papers
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation
|Nature Medicine|1999|575
Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia
|Journal of Cerebral Blood Flow & Metabolism|1999|552
Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium
|The Journal of Experimental Medicine|2003|496
CD39 is the dominant Langerhans cell–associated ecto-NTPDase: Modulatory roles in inflammation and immune responsiveness
|Nature Medicine|2002|332
CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease
|Proceedings of the National Academy of Sciences|2009|284